Growth Metrics

Omeros (OMER) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -114.28%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -674.01%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -122.45%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -25.45%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -25.45%
Dec 31, 2025 219.12%
Sep 30, 2025 -119.04%
Jun 30, 2025 -70.89%
Mar 31, 2025 162.24%
Dec 31, 2024 -69.93%
Sep 30, 2024 -36.96%
Jun 30, 2024 106.78%
Mar 31, 2024 65.85%
Dec 31, 2023 207.15%
Sep 30, 2023 73.24%
Jun 30, 2023 42.98%
Mar 31, 2023 -136.07%
Dec 31, 2022 -196.51%
Sep 30, 2022 84.39%
Jun 30, 2022 -18.64%
Mar 31, 2022 -332.87%
Dec 31, 2021 1,305.93%
Sep 30, 2021 115.12%
Jun 30, 2021 -6.70%
Mar 31, 2021 206.10%
Dec 31, 2020 120.38%
Sep 30, 2020 -1,367.77%
Jun 30, 2020 114.27%
Mar 31, 2020 -4.53%
Dec 31, 2019 -1,561.97%
Sep 30, 2019 -71.75%
Jun 30, 2019 207.89%
Mar 31, 2019 32.06%
Dec 31, 2018 -143.46%
Sep 30, 2018 155.53%
Jun 30, 2018 -341.17%
Mar 31, 2018 -19.85%
Dec 31, 2017 190.37%
Sep 30, 2017 -189.87%
Jun 30, 2017 232.38%
Mar 31, 2017 -27.12%
Dec 31, 2016 -180.72%
Sep 30, 2016 -242.50%
Jun 30, 2016 -122.51%
Mar 31, 2016 123.57%
Dec 31, 2015 -48.58%
Sep 30, 2015 -3.18%
Jun 30, 2015 24.99%
Mar 31, 2015 -59.57%
Dec 31, 2014 393.40%
Sep 30, 2014 42.46%
Jun 30, 2014 348.72%
Mar 31, 2014 -546.89%
Dec 31, 2013 -159.24%
Sep 30, 2013 135.23%
Jun 30, 2013 -950.67%
Mar 31, 2013 -55.75%
Dec 31, 2012 13.22%
Sep 30, 2012 -725.32%
Jun 30, 2012 -88.57%
Mar 31, 2012 1,269.92%
Dec 31, 2011 204.43%
Sep 30, 2011 -33.58%